380 related articles for article (PubMed ID: 2904568)
1. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
[TBL] [Abstract][Full Text] [Related]
2. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
Goodwin CS; Marshall BJ; Blincow ED; Wilson DH; Blackbourn S; Phillips M
J Clin Pathol; 1988 Feb; 41(2):207-10. PubMed ID: 3280609
[TBL] [Abstract][Full Text] [Related]
3. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
[No Abstract] [Full Text] [Related]
4. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
Rauws EA; Tytgat GN
Lancet; 1990 May; 335(8700):1233-5. PubMed ID: 1971318
[TBL] [Abstract][Full Text] [Related]
5. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
[TBL] [Abstract][Full Text] [Related]
6. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
[TBL] [Abstract][Full Text] [Related]
8. Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.
Humphreys H; Bourke S; Dooley C; McKenna D; Power B; Keane CT; Sweeney EC; O'Moráin C
Gut; 1988 Mar; 29(3):279-83. PubMed ID: 3356357
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
10. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
Miller JP
Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
[TBL] [Abstract][Full Text] [Related]
12. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone.
Bianchi Porro G; Parente F; Lazzaroni M
Gut; 1993 Apr; 34(4):466-9. PubMed ID: 8491391
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
Hu FL; Jia BQ; Gao HZ
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.
Coghlan JG; Gilligan D; Humphries H; McKenna D; Dooley C; Sweeney E; Keane C; O'Morain C
Lancet; 1987 Nov; 2(8568):1109-11. PubMed ID: 2890019
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
O'Riordan T; Mathai E; Tobin E; McKenna D; Keane C; Sweeney E; O'Morain C
Gut; 1990 Sep; 31(9):999-1002. PubMed ID: 2210469
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
Eberhardt R; Kasper G
Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
20. Bismuth: effects on gastritis and peptic ulcer.
Rokkas T; Sladen GE
Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
